Current Challenges in the Manufacturing of Injectable Drug Products

Abstract

The manufacture of injectable pharmaceuticals presents challenges from many perspectives, especially for products that must be processed aseptically and cannot be terminally sterilized. Food and Drug Administration (FDA) inspections for Good Manufacturing Practice (GMP) compliance in injectable drug product manufacturing facilities commonly find problems in the following areas